PPMI kullanarak gelişmiş Parkinson hastalığının uzun vadeli risk katmanlaşması için veri odaklı bir çerçeve.

Araştırma özeti

Aşağıdaki metin kaynak makalenin lisansı doğrulanmış orijinal özetidir. cc by

Advanced Parkinson disease has prognostic and therapeutic implications, yet staging tools are qualitative and difficult to operationalize for longitudinal modelling and cross-cohort comparison. We developed a reproducible operationalization that translates the 13-item Diagnostic Criteria for Advanced Parkinson Disease questionnaire into structured variables and generates longitudinal labels capturing certainty of advanced disease. In the Parkinson's Progression Markers Initiative near-diagnosis cohort (n = 1,302; up to 13 years), we applied this pipeline to characterize label trajectories and face validity over time. As a proof of utility, we used baseline clinical and genetic features to forecast advanced disease at years 7-11, explicitly separating forecasting from contemporaneous staging. Using a binary long-horizon endpoint, the best year-9 model showed an area under the receiver operating characteristic curve of 0.89 (95% CI 0.81-0.97). In an independent real-world cohort with ≥ 11 years follow-up (n = 35), discrimination attenuated (0.55-0.61), consistent with dataset shift and limited event counts.

İlgili konular